期刊文献+

微量白蛋白尿对于IgA肾病患者的临床、病理研究 被引量:5

Clinicopathological study of IgA nephropathy patients with microalbuminuria
下载PDF
导出
摘要 目的总结表现为微量白蛋白尿的IgA肾病(IgAN)患者的临床及病理的特点,探讨微量白蛋白尿对于IgAN的病理改变及预后的影响。方法对90例微量白蛋白尿IgAN患者的临床和病理资料进行回顾性分析,探讨其相关性。结果 90例临床表现为微量白蛋白尿的IgAN患者中,14例(15.6%)存在肾功能异常,18.4%的肾功能正常的患者中存在LeeⅢ级以上的病理损害,多因素logistic回归分析显示微量白蛋白尿是IgAN病理损伤的独立危险因素。结论微量白蛋白尿是IgAN病理损伤的独立危险因素,临床表现为微量白蛋白尿的IgAN患者的病理损伤亦可能较重,微量白蛋白尿可影响IgAN患者的预后。 Objective:To Summarize the clinicopathological features of IgA nephrology( IgAN)patients with microalbu-minuria and investigate the influence of microalbuminuria to IgA nephropathy pathological changes and prognosis. Methods:The clinical and pathological data of all IgAN patients with microalbuminuria was retrospectively analyzed,to discuss the correlation. Results:14 cases(15. 6%)of IgA nephrology(IgAN)patients with clinical manifestations included microalbu-minuria existed abnormal renal function,18. 4% of patients with normal renal function existed pathological damage accord-ing with Lee’s grade Ⅲ or more severe. Multifactor logistic regression analysis revealed that microalbuminuria was inde-pendent risk factors for renal pathological lesions of IgA nephropathy. Conclusions:Microalbuminuria is independent risk factors for renal pathological lesions of IgA nephropathy,severe renal histological injury may be seen in some IgAN patients with microalbuminuria,and microalbuminuria effects the prognosis of these patients.
出处 《泰山医学院学报》 CAS 2014年第4期250-253,共4页 Journal of Taishan Medical College
关键词 IGAN 微量白蛋白尿 临床表现 肾脏病理 IgA nephropathy microalbuminuria clinical manifestations kidney pathology
  • 相关文献

参考文献13

  • 1Floege J, Feehally J. lea nephropathy: recent developments [J]. JAm Soc Nephrol,2000,ll(12) :2395 - 2403.
  • 2Goto M, Wakai K, Kawamura T, et al. A scoring system to predictrenal outcome in IgA nephropathy:a nationwide 10 year prospectivecohort study [J]. Nephrol Dial Transplant,2009,24:3068 -3074.
  • 3Manno C,Torres DD,Rossini M,et al. Randomized controlled clini-cal trial of corticosteroids plus ACE - inhibitors with long - termfollow - up in proteinuric IgA nephropathy [J]. Nephrol DialTransplant,2009,24( 12) : 3694.
  • 4吕继成,张宏,刘刚,江建青,王海燕.IgA肾病呈单纯血尿和(或)轻度蛋白尿临床病理分析[J].中华肾脏病杂志,2004,20(6):418-420. 被引量:46
  • 5Shen PC,He LQ,Tang Y,et al. Clinicopathological characteristicsand prognostic factors of asymptomatie IgA nephropathy[J]. J In-vestig Med,2010,58(3) :560-565.
  • 6Lee SM,Rao VM,Franklin WA,et ai. IgA nephropathy:morpholog-ic predictors of progressive renal disease [J]. Hum Pathol, 1982,13:314-322.
  • 7Katafuchi R,Kiyoshi Y,Oh Y,et al. Glomerular score as a prognos-ticator in IgA nephropathy : its usefulness and limitation [J]. ClinNephrol ,1998,49:1 -8.
  • 8Donadio Jv,Grande JP. IgA nephropathy [J]. N Engl J Med,2002,347:738-748.
  • 9Szeto CC,Lai FM, To KF,et al. The natural history of immunoglobu-lin A nephropathy among patients with hematuria and minimal pro-teinuria [J].AmJ Med,2001,110:434-437.
  • 10Li Ls,Liu ZH. Epidemiologic data of renal diseases from a singleunit in china:analysis based on 13519 renal biopsies [J]. KidneyInt,2004,66(3) :920-923.

二级参考文献10

  • 1Rekola S, Bergstrand A, Bucht H, et al. Deterioration of GFR in IgA nephropathy as measured by Cr-EDTA clearance. Kidney Int,1991, 40: 1050-1054.
  • 2D'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis,2000, 36: 227-37.
  • 3Schena, F.P. Immunoglobin A nephropathy with mild renal lesions: a call in the forest for physicians and nephrologists. Am J Med, 2001, 110:499-500.
  • 4Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis, 1997, 29:829-842.
  • 5Szeto CC, Lai FM-M, To KF, et al. The natural history of immunoglobin A nephropathy among patients with hematuria and miniral proteinuria. Am J Med, 2001, 110: 434-437.
  • 6Lai FM-M, Szeto CC, Choi PC, et al. Characterization of early IgA nephropathy. Am J Kidney Dis, 2000, 36: 401-406.
  • 7Praga M, Eduardo G, Ester G, et al. Treatment of IgA nephropathy with ACE inhibitors: A Randomized and Controlled Trial. J Am Soc Nephrol, 2003, 14: 1578-1583.
  • 8郝翠兰,陈瑾君,张慧新,盛征,俞建民,储谦,董德长.524例IgA肾病的临床与病理分析[J].中华肾脏病杂志,2000,16(5):324-327. 被引量:41
  • 9邹万忠.肾活检病理诊断标准指导意见[J].中华肾脏病杂志,2001,17(4):270-274. 被引量:379
  • 10刘建华,何威逊,罗运九,朱光华,任志德.儿童C_(1q)肾病临床病理研究[J].中国中西医结合肾病杂志,2002,3(2):94-97. 被引量:32

共引文献45

同被引文献55

  • 1陈香美,陈以平,李平,陈建,谌贻璞,周柱亮,陈威,赵宗江,危成筠,魏日胞,邓跃毅,李建军,杜婧,周瑾,何亚妮.1016例IgA肾病患者中医证候的多中心流行病学调查及相关因素分析[J].中国中西医结合杂志,2006,26(3):197-201. 被引量:234
  • 2Wyatt RJ, Julian BA. IgA nepbropathy [ J ]. N Eng J Med,2013,368 (25):2402-2414.
  • 3Lee SM, Rao VM, Franklin WA, et al. IgA nephropathy : morpholog- ic predictors of progressive renal disease[J]. Hum Pathol, 1982, 13(4) :314-322.
  • 4Walsh M, Sar A,Lee D,et ah Histopathologic features aid in pre- dicting risk for progression of IgA nephropathy[ J]. Clin J Am Soc Nephrol, 2010,5 ( 3 ) :425-430.
  • 5Lv J, Ehteshami P, Sarnak M J, et al. Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis [ J]. CMAJ,2013,185 (11) : 949-957.
  • 6Zhao N, Hou P, Lv J, et al. The level of galactose-defieient lgA1 in the sera of patients with IgA nephropathy is associated with disease progression [J].Kidney Int,2012,82 ( 7 ) : 790 -796.
  • 7Berthoux F, Suzuki H, Thibaudin L, et al. Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropa- thy [J ]. J Am Soc Nephro1,2012,23 ( 9 ) : 1579-1587.
  • 8Tang SC, Tang AW, Wong SS,et al. Long -term study of myco- phenolate mofetil treatment in IgA nephropathy[J]. Kidney Int, 2010,77 (6) :543-549.
  • 9Lv J, Shi S, Xu D, et al. Evaluation of the Oxford Classification of IgA nephropathy : a systematic review and meta-analysis [ J ]. Am J Kidney Dis,2013,62(5) :891-899.
  • 10Wyatt RJ, Julian BA. IgA nephropathy[J]. N Eng J Med,2013, 368(25) :2402-2414. DOI: 10. 1056/NEJMra1206793.

引证文献5

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部